#news #biotech Eli Lilly pens $1.5B biobucks pact with China’s Regor for metabolic disease work

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Eli Lilly pens $1.5B biobucks pact with China’s Regor for metabolic disease work .Eli Lilly pens $1.5B biobucks pact with China’s Regor for metabolic disease work
badams
Fri, 12/10/2021 – 06:49

from FierceBiotech: Biotech https://ift.tt/3pEKKdM